|
|
Clinical effect of Enterprise stent combined with coil embolization in the interventional treatment of intracranial wide-necked aneurysms |
ZHANG Longhui, CHEN Min, ZHA Zhengjiang, LUO Bin, CHENG Shaowen, SHI Zhengsheng |
Department of Neurosurgery, Anqing Municipal Hospital, Anqing 246000, China |
|
|
Abstract Objective To observe the clinical effect of Enterprise stent combined with coil embolization in the interventional treatment of intracranial wide-necked aneurysms (IWA). Methods The data of patients with IWA admitted to our hospital from September 2021 to June 2023 were retrospectively analyzed. According to the use of stents, they were divided into LVIS group (LVIS stent combined with coil embolization) and Enterprise group (Enterprise stent combined with coil embolization). The propensity score matching method (the caliper value was set to 0.01, and the two groups were matched by 1: 1. Finally, 54 patients with balanced baseline data were obtained in each group. The effect of aneurysm embolization (immediately after operation, 6 months after operation, postoperative complications (aneurysm rebleeding, vasospasm, stent thrombosis), prognosis [modified Rankin scale (mRs) ], quality of life (SF-36) were compared between the both groups. Results At 6 months after surgery, the embolization effect in LVIS group and Enterprise group revealed that there was no statistical difference by rank sum test compared with that immediately after surgery. Rank sum test showed no statistical significance in the embolization effect between groups immediately after surgery and at 6 months after surgery. There were no statistical differences in complications between groups. At discharge, chi-square test revealed no statistical significance in the prognosis between both groups. At 6 months after surgery, the prognosis in LVIS group and Enterprise group was better than that at discharge by chi-square test, but no statistical difference was shown in prognosis between groups at 6 months after surgery. At 6 months after surgery, SF-36 score in LVIS group and Enterprise group was risen compared to before surgery by paired t test, and the difference before surgery and at 6 months after surgery between groups showed no statistical difference by t test. Conclusion The effect of Enterprise stent combined with coil embolization and LVIS stent combined with coil embolization IWA is equivalent, which can significantly advance quality of life of patients, but the short-term effect of Enterprise stent assisted treatment is not as good as LVIS stent.
|
Received: 27 April 2024
|
|
|
|
|
[1] 李宏建. 多发性颅内动脉瘤患者后续发生蛛网膜下腔出血的相关因素[J]. 国际脑血管病杂志, 2021, 29(9): 670. [2] 刘涛, 朱晓锋, 马俊, 等. 颅内后交通动脉瘤破裂出血的临床特征和形态学的危险因素[J]. 昆明医科大学学报, 2021, 42(12): 67-73. [3] 中华医学会神经外科学分会神经介入学组. 颅内动脉瘤血管内介入治疗中国专家共识 (2013)[J]. 中华医学杂志, 2013, 93(39): 3093-3103. [4] 刘鹏程, 罗有才. 颅内自膨式支架系统辅助弹簧圈栓塞术治疗颅内宽颈动脉瘤近期疗效观察[J]. 陕西医学杂志, 2019, 48(8): 1056-1058. [5] 刘建民. 颅内动脉瘤的血管内治疗——从血管重建到血流重构[J]. 中华神经外科杂志, 2019, 35(9): 865-867. [6] 中国医师协会神经介入专业委员会, 中国颅内动脉瘤计划研究组. 颅内动脉瘤影像学判读专家共识[J]. 中国脑血管病杂志, 2021, 18(7): 492-504. [7] LINDE JJ, KELBÆK H, HANSEN TF, et al. Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome[J]. J Am Coll Cardiol, 2020, 75(5): 453-463. [8] LIU F, TSANG RC, ZHOU J, et al.Relationship of Barthel Index and its Short Form with the Modified Rankin Scale in acute stroke patients[J]. J Stroke Cerebrovasc Dis, 2020, 29(9): 105033. [9] 鲁洁, 刘苏伟, 买买提力·艾沙, 等. 颅内动脉瘤患者术后生存质量现状及影响因素分析[J]. 中国医药导报, 2021, 18(20): 70-73. [10] 裘天仑. 颅内动脉瘤形态对血流动力学的影响及破裂风险研究[J]. 浙江医学, 2019, 41(19): 2049-2053+2071. [11] 张建民, 王勇杰. 动脉瘤破裂和动脉瘤性蛛网膜下腔出血诊治进展[J]. 浙江医学, 2023, 45(14): 1457-1460. [12] 丰伟, 康俊龙, 陈锷. 颅内镜像动脉瘤弹簧圈栓塞治疗体会[J]. 中国临床神经外科杂志, 2022, 27(12): 1020-1021. [13] 袁璞, 徐瀚, 聂文臣, 等. 脑动脉瘤破裂患者脑动脉瘤颈部宽度与弹簧圈栓塞术后复发的相关性分析[J]. 哈尔滨医科大学学报, 2022, 56(6): 603-607. [14] CHEN F, FANG X.Endovascular treatment of middle cerebral artery aneurysm with a (LVIS) device: Comparison of LVIS stent and non-LVIS stent[J]. Exp Ther Med, 2019, 17(3): 1656-1662. [15] 刘珍, 王辉, 肖仕和, 等. 颅内宽颈动脉瘤破裂急性期LVIS支架辅助弹簧圈栓塞治疗[J]. 国际神经病学神经外科学杂志, 2020, 47(3): 239-243. [16] 李立, 李天晓, 薛绛宇, 等. LVIS支架辅助栓塞未破裂颅内宽颈动脉瘤[J]. 中华神经外科杂志, 2019, 35(8): 833-836. [17] 刘远来, 孙异春, 何永超, 等. Solitaire支架与lvis支架辅助弹簧圈栓塞对颅内宽颈动脉瘤的疗效对比[J]. 南方医科大学学报, 2020, 40(3): 423-426. [18] 徐德才, 李健, 张弢, 等. 闭环支架半释放技术在颅内宽颈动脉瘤血管内介入治疗中的应用[J]. 中国微创外科杂志, 2023, 23(5): 341-346. [19] 裴本根, 张玉华, 计跃, 等. Enterprise支架在前循环破裂宽颈动脉瘤治疗中对患者认知功能影响研究[J]. 临床军医杂志, 2019, 47(7): 706-707. [20] 刘钊, 陈鹏, 车彦军, 等. 对比性分析LVIS支架和Enterprise支架辅助弹簧圈栓塞颅内破裂宽颈动脉瘤的安全性和有效性[J]. 临床神经外科杂志, 2022, 19(6): 693-698. |
|
|
|